$5.22
Applied Therapeutics is a biotechnology business based in the US. Applied Therapeutics shares (APLT) are listed on the NASDAQ and all prices are listed in US Dollars. Applied Therapeutics employs 26 staff and has a market cap (total outstanding shares value) of 0.00.
Our top picks for where to buy Applied Therapeutics stock
How to buy Applied Therapeutics stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – APLT. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Applied Therapeutics stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Applied Therapeutics stock price (NASDAQ: APLT)
Use our graph to track the performance of APLT stocks over time.Applied Therapeutics shares at a glance
Latest market close | $5.20 |
---|---|
52-week range | $1.18 - $9.39 |
50-day moving average | $4.68 |
200-day moving average | $3.99 |
Wall St. target price | $11.40 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-1.91 |
Is it a good time to buy Applied Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Applied Therapeutics price performance over time
Historical closes compared with the close of $5.2 from 2024-07-25
1 week (2024-07-19) | 1.17% |
---|---|
1 month (2024-06-27) | 13.04% |
3 months (2024-04-26) | 21.50% |
6 months (2024-01-26) | 78.69% |
1 year (2023-07-27) | 246.67% |
---|---|
2 years (2022-07-27) | 409.80% |
3 years (2021-07-27) | 17.52 |
5 years (2019-07-26) | 8.75 |
Applied Therapeutics financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -51.57% |
Return on equity TTM | -612.33% |
Profit margin | 0% |
Book value | $0.59 |
Market Capitalization | $587.3 million |
TTM: trailing 12 months
Applied Therapeutics share dividends
We're not expecting Applied Therapeutics to pay a dividend over the next 12 months.
Applied Therapeutics share price volatility
Over the last 12 months, Applied Therapeutics's shares have ranged in value from as little as $1.18 up to $9.39. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Applied Therapeutics's is 1.992. This would suggest that Applied Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Applied Therapeutics overview
Applied Therapeutics, Inc. , a clinical-stage biopharmaceutical company, engages in the development of a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need in the United States. The company's lead product candidate is AT-007 (also called govorestat) that has completed phase 3 for the treatment of galactosemia in healthy volunteers and adults, in pediatric clinical study for the treatment of galactosemia in kids, for treating enzyme sorbitol dehydrogenase, and for the treatment of phosphomannomutase enzyme-CDG. It also develops AT-001 (also called caficrestat) that is in phase 3 clinical trials to treat diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy; and AT-003, which is in preclinical studies for the treatment diabetic retinopathy. The company has exclusive license and supply agreement with Mercury Pharma Group Limited to commercialize drug products containing AT-007. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.
Frequently asked questions
nullWhat percentage of Applied Therapeutics is owned by insiders or institutions?
Currently 5.951% of Applied Therapeutics shares are held by insiders and 87.712% by institutions. How many people work for Applied Therapeutics?
Latest data suggests 26 work at Applied Therapeutics. When does the fiscal year end for Applied Therapeutics?
Applied Therapeutics's fiscal year ends in December. Where is Applied Therapeutics based?
Applied Therapeutics's address is: 545 Fifth Avenue, New York, NY, United States, 10017 What is Applied Therapeutics's ISIN number?
Applied Therapeutics's international securities identification number is: US03828A1016 What is Applied Therapeutics's CUSIP number?
Applied Therapeutics's Committee on Uniform Securities Identification Procedures number is: 03828A101
More guides on Finder
-
Opto review 2024: $0 commission, fractional theme investing
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
Put options explained
Learn the basics of put options: what they are, how they work and a few examples.
-
Best broker cash sweep rates for July 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 best day trading platforms of July 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
11 apps like Webull you need to consider
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
7 best ways to invest $10K
Check out our 7 ideas for how to invest $10K to maximize your money.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question